Decision Resources, Inc., June 2006, Pages: 23
. Historically, however, Medicare offered only limited coverage of prescription medicines. To improve beneficiaries’ access to outpatient prescription medicines, the Medicare Prescription Drug, Improvement
Decision Resources, Inc., Dec 2009, Pages: 58
cation of Targeted Cancer Therapies
Registry of Oncology Drugs Subject to Monitoring
Regional Variations in Coverage
Hospital Reimbursement
Conditional Reimbursement Agreements
Spain
Recent
Decision Resources, Inc., May 2007, Pages: 23
are they purported to offer, and what are their chances of being made into law?
- According to the Centers for Medicare and Medicaid Services, the Medicare Part D prescription drug benefit is saving beneficiaries
Decision Resources, Inc., March 2011, Pages: 70
of their formularies. Which leading drugs have the most and least favorable placement? How do Medicare plans compare with commercial plans in their positioning of metabolic disease therapies? Which coverage restrictions
MP Advisors, Aug 2011
Medicines- Donut hole and drug-drug interaction
Regulatory Scenario – Medicare Shared Saving program to be implemented in 2012
Physician's Experience and cost effectiveness
- Warfarin continues to hold
HealthLeaders Interstudy, May 2011, Pages: 49
will be closely monitored. At the same time, bundled payment will force providers to squeeze every excess penny of out of the system, which may affect sales of branded drugs. Whatever the outcome, we expect drug
Frost & Sullivan, Feb 2012
industry leaders and financial services firms to identify and monitor companies that may prove to be ideal technology partners or acquisition targets. In addition, this information keeps market participants
Axis Research Mind, Feb 2011, Pages: 391
.
BRICSS cardiac monitoring and diagnostic devices market forecasts to reach at US$2.4 billion by 2015 at a CAGR of 12% during the analysis period 2009-2015. China accounts for nearly 25% of the global value
Decision Resources, Inc., July 2008, Pages: 40
des Lois de Financement de la Sécurité Sociale (MECSS; Commission for the Evaluation and Monitoring of Social Security Finance Laws), France
- National Drug Center
- National Health Service (NHS
WinterGreen Research, Inc., June 2011, Pages: 443
Of Physiological Data
Telemonitoring Market Shares
Tele-Monitoring Market Forecasts
Telemonitor Assessment
Partners HealthCare
Bosch Health Buddy Deployments with Medicare, VA
VA Telehealth Results
Jain PharmaBiotech, Feb 2012, Pages: 534
Clinical trials for AD
Drugs for AD that were discontinued in clinical trials
Evaluation of clinical trials of AD
Monitoring of cognitive function during clinical trials
Drug discovery for AD
Drugs
Business Insights, June 2010, Pages: 191
stratification, drug regimen selection, toxicity avoidance, therapeutic monitoring, and detection of predisposition to disease. Hospitals and diagnostic laboratories using molecular diagnostic techniques need
Decision Resources, Inc., Sep 2008, Pages: 44
Advertising
-Medicare Improvements for Patients and Providers Act of 2008
Select Proposed Legislation in the 110th Congress
-Pharmaceutical Market Access and Drug Safety Act: Addressing the Issue of Drug
Decision Resources, Inc., Oct 2005, Pages: 21
States, France, Germany, Italy, Spain, United Kingdom, and Japan), including the ongoing preparations for implementation of the Medicaredrug benefit plan in the United States and a new European Union
Global Industry Analysts, Inc., Oct 2011, Pages: 749
biologics that offer superior efficacy over conventional therapeutic options. In addition, inclusion of self-administered drugs in Medicare Part D program enhanced market reach of these drugs. European
Plunkett Research, Ltd, Nov 2011, Pages: 714
Years, 2005-2020
9) Prescription Drug Expenditures, U.S.: 1965-2020
10) Medicare Enrollment, 1970-2085
11) Number & Percent of Persons of All Ages without Health Insurance Coverage, by Race/Ethnicity, U
Axis Research Mind, Feb 2011, Pages: 363
25% of the market. In terms of CAGR, India and China are the fastest growing regions while South Korea and Russia are just behind. Forecasts for drug eluting stent types indicate a close 65% while bare
Frost & Sullivan, Jan 1998
Climate
- Innovations in Drug Cost Containment
- Overview of the Insurance Market
- Prescription DrugReimbursement from Government Sources
- Market Overview
- Medicaid Program
- Medicare
